GDF-15 is significantly associated with outcome for solid tumors as breast cancer, lung cancer or gastrointestinal cancer; however, no association with outcome could be shown for hematological cancers as myelodysplastic or myeloproliferative diseases. Here, GDF15 is linked to breast carcinoma.